Login / Signup

Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms.

Marek SaracynAdam Daniel DurmaBarbara BoberMaciej KolodziejArkadiusz LubasWaldemar KapustaStanisław NiemczykGrzegorz Kamiński
Published in: Nutrients (2022)
Though low-grade complications of radioligand therapy are possible, it stay a safe method of NEN treatment where benefits outweigh the risk.
Keyphrases
  • low grade
  • high grade
  • risk factors
  • stem cells
  • replacement therapy